Will be interesting to see if provisions for bad debt are stable in the HY report . Guess we could see a spike in cash flow if these outstanding payments flow through.
my biggest concern is $3.1M in adapt is the same as it was a year ago. The market does not seem to be responding to cardiocel 3d in the way I hoped it might. This product should be selling itself...
Ann: Appendix 4C - quarterly, page-35
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M | |||
| Open | High | Low | Value | Volume |
| $10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $9.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.91 | 475 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |